# A Natural History Study of Aspartylglucosaminuria

> **NCT03853876** · — · TERMINATED · sponsor: **Neurogene Inc.** · enrollment: 8 (actual)

## Conditions studied

- Aspartylglucosaminuria
- Aspartylglucosamidase (AGA) Deficiency
- Lysosomal Storage Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03853876
- **Lead sponsor:** Neurogene Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-18
- **Primary completion:** 2020-10-15
- **Final completion:** 2022-03-17
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Discontinued AGU development program
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03853876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03853876, "A Natural History Study of Aspartylglucosaminuria". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03853876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*